Nucleophile responsive charge-reversing polycations for pDNA transfection

Journal Article (2023)
Authors

Reece W. Lewis (TU Delft - ChemE/Advanced Soft Matter)

A. Muralidharan (TU Delft - BN/Bionanoscience, Kavli institute of nanoscience Delft, TU Delft - BN/Stan Brouns Lab)

B. Klemm (TU Delft - ChemE/Advanced Soft Matter)

PE Boukany (TU Delft - ChemE/Product and Process Engineering)

R Eelkema (TU Delft - ChemE/Advanced Soft Matter)

Research Group
BN/Stan Brouns Lab
Copyright
© 2023 R.W. Lewis, A. Muralidharan, B. Klemm, P. Boukany, R. Eelkema
To reference this document use:
https://doi.org/10.1039/d3py00075c
More Info
expand_more
Publication Year
2023
Language
English
Copyright
© 2023 R.W. Lewis, A. Muralidharan, B. Klemm, P. Boukany, R. Eelkema
Research Group
BN/Stan Brouns Lab
Issue number
14
Volume number
14
Pages (from-to)
1591-1601
DOI:
https://doi.org/10.1039/d3py00075c
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Polycationic carriers promise low cost and scalable gene therapy treatments, however inefficient intracellular unpacking of the genetic cargo has limited transfection efficiency. Charge-reversing polycations, which transition from cationic to neutral or negative charge, can offer targeted intracellular DNA release. We describe a new class of charge-reversing polycation which undergoes a cationic-to-neutral conversion by a reaction with cellular nucleophiles. The deionization reaction is relatively slow with primary amines, and much faster with thiols. In mammalian cells, the intracellular environment has elevated concentrations of amino acids (∼10×) and the thiol glutathione (∼1000×). We propose this allows for decationization of the polymeric carrier slowly in the extracellular space and then rapidly in the intracellular milleu for DNA release. We demonstrate that in a lipopolyplex formulation this leads to both improved transfection and reduced cytotoxicity when compared to a non-responsive polycationic control.